HIV/AIDS News and Research RSS Feed - HIV/AIDS News and Research Twitter

First confirmed case of Alzheimer’s disease in HIV-positive patient to be presented at AAIC 2016

First confirmed case of Alzheimer’s disease in HIV-positive patient to be presented at AAIC 2016

The first case of Alzheimer's disease diagnosed in an HIV-positive individual will be presented in a poster session at the Alzheimer's Association International Conference 2016 in Toronto July 27. [More]
Penn researchers construct model to examine how immune system may evolve to conquer HIV

Penn researchers construct model to examine how immune system may evolve to conquer HIV

It has remained frustratingly difficult to develop a vaccine for HIV/AIDS, in part because the virus, once in our bodies, rapidly reproduces and evolves to escape being killed by the immune system. [More]
Improving efficiency of health facilities could extend ART to many people living with HIV

Improving efficiency of health facilities could extend ART to many people living with HIV

Health facilities in Kenya, Uganda, and Zambia could extend life-sustaining antiretroviral therapy (ART) to hundreds of thousands of people living with HIV if facilities improved the efficiency of service delivery. [More]
WHO urges countries to take rapid action to reduce new infections, deaths from viral hepatitis

WHO urges countries to take rapid action to reduce new infections, deaths from viral hepatitis

Ahead of World Hepatitis Day, 28 July 2016, WHO is urging countries to take rapid action to improve knowledge about the disease, and to increase access to testing and treatment services. [More]
Study confirms efficacy of PrEP in reducing risk of HIV infection in men who have sex with men

Study confirms efficacy of PrEP in reducing risk of HIV infection in men who have sex with men

The last phase of ANRS IPERGAY has confirmed that "on-demand" pre-exposure prophylaxis (PrEP) is a highly effective method of reducing the risk of HIV infection in men who have sex with men and who report high-risk behavior. [More]
New HIV infections stagnating globally at 2.5 million per year, study reveals

New HIV infections stagnating globally at 2.5 million per year, study reveals

A major new analysis from the Global Burden of Disease 2015 study, published today in The Lancet HIV journal, reveals that although deaths from HIV/AIDS have been steadily declining from a peak in 2005, 2.5 million people worldwide became newly infected with HIV in 2015, a number that hasn't changed substantially in the past 10 years. [More]
Increasing rates of new HIV infections threaten 74 countries

Increasing rates of new HIV infections threaten 74 countries

AIDS deaths are falling in most countries worldwide, but the rate of new infections increased in several countries over the past decade, threatening to undermine efforts to end the AIDS epidemic by 2030, a new scientific paper shows. [More]
Anti-HIV medications provide durable protection against heterosexual transmission, study finds

Anti-HIV medications provide durable protection against heterosexual transmission, study finds

Anti-HIV medications suppress the viral load of people living with HIV and provide durable protection against heterosexual transmission a study led by the University of North Carolina at Chapel Hill found. [More]
First clinical study for Zika vaccine to begin in Canada

First clinical study for Zika vaccine to begin in Canada

Université Laval's Infectious Disease Research Centre and Centre de recherche du CHU de Québec-Université Laval are proud to announce that the first clinical study for a Zika vaccine in Canada is set to begin in Quebec City. [More]
Researchers design inhibitory peptide to unleash defence mechanisms against fungal pathogens

Researchers design inhibitory peptide to unleash defence mechanisms against fungal pathogens

For most people, a simple case of thrush or athlete's foot can be quickly and easily treated using over-the-counter anti-fungal creams and pills. [More]
Mass incarceration of drug users leads to high levels of HIV, tuberculosis and hepatitis among prisoners

Mass incarceration of drug users leads to high levels of HIV, tuberculosis and hepatitis among prisoners

The War on Drugs, mass incarceration of drug users, and the failure to provide proven harm reduction and treatment strategies has led to high levels of HIV, tuberculosis, and hepatitis B and C infection among prisoners—far higher than in the general population. [More]
IAEA study: Maternal HIV status does not influence growth, breast milk intake of HIV-negative infants

IAEA study: Maternal HIV status does not influence growth, breast milk intake of HIV-negative infants

There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found. [More]
HOPE study seeks to understand safety of vaginal ring in protecting women against HIV

HOPE study seeks to understand safety of vaginal ring in protecting women against HIV

Women who took part in ASPIRE, a trial that found a vaginal ring containing an antiretroviral (ARV) drug called dapivirine was safe and helped protect against HIV, will soon be offered the opportunity to use the ring as part of a new study called HOPE. [More]
IDSA/ATS recommends shorter courses of antibiotics for patients with hospital-acquired, ventilator-associated pneumonia

IDSA/ATS recommends shorter courses of antibiotics for patients with hospital-acquired, ventilator-associated pneumonia

Hospital-acquired pneumonia and ventilator-associated pneumonia– which account for 20 to 25 percent of hospital-acquired infections – should be treated with shorter courses of antibiotics than they typically are, according to new guidelines released by the Infectious Diseases Society of America and American Thoracic Society and published in the journal Clinical Infectious Diseases. [More]
Researchers receive grant to test transcutaneously refillable implant that delivers HIV-prevention drugs

Researchers receive grant to test transcutaneously refillable implant that delivers HIV-prevention drugs

A Houston Methodist research team received a nearly $4 million grant to test a transcutaneously refillable implant that administers pre-exposure prophylaxis drugs to subjects at risk of HIV-exposure. [More]

Community-level ART coverage, male circumcision linked to decline in new male HIV infections in Uganda

Increasing the number of men who undergo circumcision and increasing the rates at which women with HIV are given antiretroviral therapy (ART) were associated with significant declines in the number of new male HIV infections in rural Ugandan communities, new Johns Hopkins Bloomberg School of Health research suggests. [More]
MGH researchers discover how obesity increases inflammation, desmoplasia in PDAC patients

MGH researchers discover how obesity increases inflammation, desmoplasia in PDAC patients

Massachusetts General Hospital investigators have discovered the mechanism by which obesity increases inflammation and desmoplasia - an accumulation of connective tissue - in the most common form of pancreatic cancer. [More]
Inherited mutations in DNA repair genes may predispose to metastatic prostate cancer

Inherited mutations in DNA repair genes may predispose to metastatic prostate cancer

Inherited mutations in genes that function to repair DNA may contribute to metastatic prostate cancer more than previously recognized, according to a study out today in the New England Journal of Medicine. [More]
New IDSA guidelines focus on diagnosis, treatment of deadly aspergillosis

New IDSA guidelines focus on diagnosis, treatment of deadly aspergillosis

New therapies are improving care, but early diagnosis remains critical in the effective treatment of invasive, a potentially deadly fungal infection, according to new guidelines released by the Infectious Diseases Society of America and published in the journal Clinical Infectious Diseases. [More]
TSRI scientists develop new strategy to design potential HIV vaccine candidates

TSRI scientists develop new strategy to design potential HIV vaccine candidates

Want to catch a criminal? Show a mugshot on the news. Want to stop HIV infections? Get the immune system to recognize and attack the virus's tell-tale structure. That's part of the basic approach behind efforts at The Scripps Research Institute to design an AIDS vaccine. [More]
Advertisement
Advertisement